Abbott Invests Millions In Clinical Trial Diversification Efforts

Abbott is investing millions of dollars in its Diversity in Research Office to diversify clinical trials in the industry.

diverse doctors
• Source: Shutterstock

Abbott’s newly created diversity in research office is providing resources and support for patients and clinicians to help diversify the company’s clinical trials.

Jennifer Jones-McMeans, Abbott’s divisional vice president of global clinical affairs, told Medtech Insight that Abbott plans to spend $5m on the initiative over the next five years.

More from Diversity & Inclusion

More from ESG